Cardiff Oncology, Inc. (LSX:A2P4GU) Financings
Financings
| Raise | Date |
|---|---|
| Registered direct offering of common stock and warrants Closed: US$10M raised · US$1.05 a share · ½ warrant at US$1.31 for 66 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Buyers: Certain officers and directors (731,707 shares and accompanying warrants at $1.435 per share and accompanying warrant) Insiders: Certain officers and directors are buying 731,707 shares and accompanying warrants at $1.435 per share and accompanying warrant Use of proceeds: Working capital and general corporate purposes | Aug 11, 2026 |